Warby Parker (WRBY) Cash from Investing Activities (2020 - 2026)
Warby Parker's (WRBY) quarterly Cash from Investing Activities came in at -$16.1 million in Q1 2026, little changed YoY from -$16.1 million in Q1 2025, and down 6.73% on a QoQ basis from -$15.1 million in Q4 2025.
Warby Parker (WRBY) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Cash from Investing Activities data on file, last reported at -$16.1 million in Q1 2026.
- Quarterly Cash from Investing Activities changed 0.09% year-over-year to -$16.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$67.0 million (down 1.96% YoY) and the FY2025 annual result came in at -$67.0 million, down 1.54% from the prior year.
- Cash from Investing Activities slipped to -$16.1 million in Q1 2026, from -$15.1 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$12.2 million in Q2 2023 to a low of -$19.5 million in Q3 2025.
- A 5-year average of -$15.5 million and a median of -$16.1 million in 2022 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 84.9% — and 2023, when it climbed 22.88%.
- Tracing WRBY's Cash from Investing Activities over 5 years: stood at -$14.2 million in 2022, then rose by 4.52% to -$13.6 million in 2023, then plunged by 30.56% to -$17.7 million in 2024, then advanced by 14.68% to -$15.1 million in 2025, then decreased by 6.73% to -$16.1 million in 2026.
- The last three Cash from Investing Activities figures came in at -$16.1 million (Q1 2026), -$15.1 million (Q4 2025), and -$19.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | -22.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.86 Mn |
| Jun 30, 2026 | -22.86 Mn |
| Mar 31, 2026 | -16.14 Mn |
| Mar 31, 2026 | -16.14 Mn |
| Dec 31, 2025 | -15.12 Mn |
| Dec 31, 2025 | -15.12 Mn |
| Sep 30, 2025 | -19.49 Mn |
| Sep 30, 2025 | -19.49 Mn |
| Jun 30, 2025 | -16.29 Mn |
| Jun 30, 2025 | -16.29 Mn |
| Mar 31, 2025 | -16.15 Mn |
| Mar 31, 2025 | -16.15 Mn |
| Dec 31, 2024 | -17.72 Mn |
| Dec 31, 2024 | -17.72 Mn |
| Sep 30, 2024 | -14.22 Mn |
| Sep 30, 2024 | -14.22 Mn |
| Jun 30, 2024 | -17.65 Mn |
| Jun 30, 2024 | -17.65 Mn |
| Mar 31, 2024 | -16.44 Mn |
| Mar 31, 2024 | -16.44 Mn |